Works matching IS 17555914 AND DT 2015 AND VI 33 AND IP 4
Results: 14
Is Foxglove Effective in Heart Failure?
- Published in:
- Cardiovascular Therapeutics, 2015, v. 33, n. 4, p. 236, doi. 10.1111/1755-5922.12130
- By:
- Publication type:
- Article
Delayed Enrichment for c-kit and Inducing Cardiac Differentiation Attenuated Protective Effects of BMSCs' Transplantation in Pig Model of Acute Myocardial Ischemia.
- Published in:
- Cardiovascular Therapeutics, 2015, v. 33, n. 4, p. 184, doi. 10.1111/1755-5922.12131
- By:
- Publication type:
- Article
Levosimendan Improves Hemodynamic Status in Critically Ill Patients with Severe Aortic Stenosis and Left Ventricular Dysfunction: An Interventional Study.
- Published in:
- Cardiovascular Therapeutics, 2015, v. 33, n. 4, p. 193, doi. 10.1111/1755-5922.12132
- By:
- Publication type:
- Article
TPEN Prevents Rapid Pacing-Induced Calcium Overload and Nitration Stress in HL-1 Myocytes.
- Published in:
- Cardiovascular Therapeutics, 2015, v. 33, n. 4, p. 200, doi. 10.1111/1755-5922.12134
- By:
- Publication type:
- Article
Administration of Antiarrhythmic Drugs to Maintain Sinus Rhythm After Catheter Ablation for Atrial Fibrillation: A Meta-Analysis.
- Published in:
- Cardiovascular Therapeutics, 2015, v. 33, n. 4, p. 242, doi. 10.1111/1755-5922.12133
- By:
- Publication type:
- Article
Underutilization of IV Nitrates in the Treatment of Acute Heart Failure.
- Published in:
- Cardiovascular Therapeutics, 2015, v. 33, n. 4, p. 247, doi. 10.1111/1755-5922.12135
- By:
- Publication type:
- Article
Eptifibatide in Post-infarction Angina Patients who refused Intervention: Ajmer Postmyocardial Infarction Angina Eptifibatide Research ( AJMER) Study: A Pilot Study.
- Published in:
- Cardiovascular Therapeutics, 2015, v. 33, n. 4, p. 155, doi. 10.1111/1755-5922.12123
- By:
- Publication type:
- Article
Influence of Antihypertensive Therapy on Cerebral Perfusion in Patients with Metabolic Syndrome: Relationship with Cognitive Function and 24-h Arterial Blood Pressure Monitoring.
- Published in:
- Cardiovascular Therapeutics, 2015, v. 33, n. 4, p. 209, doi. 10.1111/1755-5922.12136
- By:
- Publication type:
- Article
Downregulation of miR-21 is Involved in Direct Actions of Ursolic Acid on the Heart: Implications for Cardiac Fibrosis and Hypertrophy.
- Published in:
- Cardiovascular Therapeutics, 2015, v. 33, n. 4, p. 161, doi. 10.1111/1755-5922.12125
- By:
- Publication type:
- Article
Bivalirudin in Percutaneous Coronary Intervention, is it the Anticoagulant of Choice?
- Published in:
- Cardiovascular Therapeutics, 2015, v. 33, n. 4, p. 227, doi. 10.1111/1755-5922.12124
- By:
- Publication type:
- Article
Modulation of Adhesion Molecules by Cholesterol-Lowering Therapy in Mononuclear Cells from Hypercholesterolemic Patients.
- Published in:
- Cardiovascular Therapeutics, 2015, v. 33, n. 4, p. 168, doi. 10.1111/1755-5922.12126
- By:
- Publication type:
- Article
A Novel Hydrogen Sulfide Prodrug, SG1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients.
- Published in:
- Cardiovascular Therapeutics, 2015, v. 33, n. 4, p. 216, doi. 10.1111/1755-5922.12128
- By:
- Publication type:
- Article
Contraindications to Anticoagulation Therapy and Eligibility for Novel Anticoagulants in Older Patients with Atrial Fibrillation.
- Published in:
- Cardiovascular Therapeutics, 2015, v. 33, n. 4, p. 177, doi. 10.1111/1755-5922.12129
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cardiovascular Therapeutics, 2015, v. 33, n. 4, p. i, doi. 10.1111/1755-5922.12140
- Publication type:
- Article